Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion type Assertion NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_head.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion description "[Of the six genes, three (SNORD33, SNORD66 and SNORD76) displayed higher plasma expressions in NSCLC patients compared with the cancer-free individuals (All < 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_provenance.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion evidence source_evidence_literature NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_provenance.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion SIO_000772 20663213 NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_provenance.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion wasDerivedFrom befree-20150227 NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_provenance.
- NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_assertion wasGeneratedBy ECO_0000203 NP1005845.RAQzNwFGeNpdnLX-0n-3M_2yk3f-B7YpHl4zKIE3pOYeQ130_provenance.